Centro Médico Teknon
Centro Médico Teknon
Hiszpania, Barcelona
Carlos Ballesta Lopez
46 lat doświadczenia
akredytacje :
Portfolio chirurga
Akredytacje :
Gallbladder cancer treatment cost in Spain typically involves essential diagnostics like a PET/CT scan, which costs $1,300 to $1,800. Primary treatment protocols often include proton-beam therapy, which runs $25,800 to $65,600, or brachytherapy. Total expenses depend on the cancer stage, surgical approach, and clinic tier, with patients saving approximately 30-50% compared to the US. Top treatment centers are located in Barcelona, Madrid, and Pamplona.
Typical Gallbladder Cancer Treatment Costs in Spain
Bookimed Expert Insight: Patients with complex hepato-biliary cases should prioritize JCI-accredited centers like Centro Médico Teknon. This facility offers robot-assisted surgery for the gallbladder and pancreas, pioneered by experts like Dr. Carlos Ballesta Lopez. For those requiring advanced peritoneal treatments, specialized oncologists at Teknon perform HIPEC cytoreductive surgery. Clinica Universidad de Navarra is ideal for international patients seeking US-standard care, holding the first JCI accreditation in Spain.
| Turcja | Austria | Hiszpania | |
| Terapia protonowa w raku prostaty | od $30,000 | od $80,000 | od $70,000 |
| Terapia protonowa przy raku piersi | od $30,000 | od $55,000 | od $85,000 |
| Terapia protonowa | od $70,000 | od $80,000 | od $25,836 |
| Chemioterapia w raku piersi | od $1,200 | od $15,000 | od $3,500 |
| Brachyterapia | od $3,465 | od $15,000 | od $10,000 |
Wykonał ponad 12 000 operacji laparoskopowych — dr Ballesta Lopez jest pionierem technik małoinwazyjnych w Centro Médico Teknon.
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.
Specjalizuje się w zaawansowanych nowotworach jamy brzusznej – dr Sabia leczy złożone przypadki nowotworów otrzewnej i pęcherzyka żółciowego w Centro Médico Teknon.